Cargando…
Testosterone replacement therapy among elderly males: the Testim Registry in the US (TRiUS)
BACKGROUND: Testosterone levels naturally decline with age in men, often resulting in testosterone deficiency (hypogonadism). However, few studies have examined hypogonadal characteristics and treatment in older (≥65 years) men. OBJECTIVE: To compare data at baseline and after 12 months of testoster...
Autores principales: | Bhattacharya, Rajib K, Khera, Mohit, Blick, Gary, Kushner, Harvey, Miner, Martin M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3430096/ https://www.ncbi.nlm.nih.gov/pubmed/22956867 http://dx.doi.org/10.2147/CIA.S32036 |
Ejemplares similares
-
Effect of 12 months of testosterone replacement therapy on metabolic syndrome components in hypogonadal men: data from the Testim Registry in the US (TRiUS)
por: Bhattacharya, Rajib K, et al.
Publicado: (2011) -
Controversies in testosterone replacement therapy: testosterone and cardiovascular disease
por: Hwang, Kathleen, et al.
Publicado: (2015) -
Controversies in testosterone supplementation therapy
por: Khera, Mohit
Publicado: (2015) -
TestIME: an application for evaluating the efficiency of Chinese input method engines in electronic medical record entry task
por: Yang, Feihong, et al.
Publicado: (2019) -
Testosterone’s Role in COVID-19
por: Auerbach, Jeremy M., et al.
Publicado: (2021)